{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:23:29Z","timestamp":1773260609246,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41401-021-00636-1","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T08:02:24Z","timestamp":1617004944000},"page":"885-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacological characterization of MT-1207, a novel multitarget antihypertensive agent"],"prefix":"10.1038","volume":"42","author":[{"given":"Tian-ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-sheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-li","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-feng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-yu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953\u20132041.","journal-title":"J Hypertens"},{"key":"636_CR2","first-page":"1","volume":"24","author":"Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee, Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, Hypertension Branch of Chinese Geriatric Medical Association","year":"2019","unstructured":"Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee, Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, Hypertension Branch of Chinese Geriatric Medical Association. et al. 2018 Chinese guidelines for the management of hypertension. Chin J Cardiovasc Med. 2019;24:1\u201342.","journal-title":"Chin J Cardiovasc Med"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tips.2005.06.003","volume":"26","author":"DF Su","year":"2005","unstructured":"Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci. 2005;26:388\u201390.","journal-title":"Trends Pharmacol Sci."},{"key":"636_CR4","unstructured":"Miao CY. Cardio-cerebro-vascular pharmacology. Beijing (CHN): Science Press; 2019."},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990\u20132015. JAMA. 2017;317:165\u201382.","journal-title":"JAMA."},{"key":"636_CR6","first-page":"448","volume":"13","author":"CY Miao","year":"1992","unstructured":"Miao CY, Zhu QY, Yang YC, Su DF. Antihypertensive effects of atenolol and nitrendipine alone or in combination on three hypertensive models of rats. Zhongguo Yao Li Xue Bao. 1992;13:448\u201351.","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00004872-200501000-00030","volume":"23","author":"HH Xie","year":"2005","unstructured":"Xie HH, Miao CY, Jiang YY, Su DF. Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats. J Hypertens. 2005;23:193\u2013201.","journal-title":"J Hypertens"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1582-4934.2008.00365.x","volume":"13","author":"P Han","year":"2009","unstructured":"Han P, Shen FM, Xie HH, Chen YY, Miao CY, Mehta JL, et al. The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats. J Cell Mol Med. 2009;13:726\u201334.","journal-title":"J Cell Mol Med"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1472-8206.2004.00200.x","volume":"18","author":"LP Xu","year":"2004","unstructured":"Xu LP, Shen FM, Shu H, Miao CY, Jiang YY, Su DF. Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats. Fundam Clin Pharmacol. 2004;18:33\u20138.","journal-title":"Fundam Clin Pharmacol"},{"key":"636_CR10","doi-asserted-by":"publisher","unstructured":"Fu YL, Tao L, Peng FH, Zheng NZ, Lin Q, Cai SY, et al. GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function. Acta Pharmacol Sin. 2020. https:\/\/doi.org\/10.1038\/s41401-020-0459-6.","DOI":"10.1038\/s41401-020-0459-6"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1745-7254.2007.00630.x","volume":"28","author":"G Ling","year":"2007","unstructured":"Ling G, Liu AJ, Shen FM, Cai GJ, Liu JG, Su DF. Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats. Acta Pharmacol Sin. 2007;28:1755\u201360.","journal-title":"Acta Pharmacol Sin."},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/aps.2009.11","volume":"30","author":"MY Wu","year":"2009","unstructured":"Wu MY, Ma XJ, Yang C, Tao X, Liu AJ, Su DF, et al. Effects of allisartan, a new AT1 receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Acta Pharmacol Sin. 2009;30:307\u201313.","journal-title":"Acta Pharmacol Sin."},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/01.hjh.0000226203.57818.88","volume":"24","author":"CY Miao","year":"2006","unstructured":"Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens. 2006;24:1125\u201335.","journal-title":"J Hypertens"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/aps.2015.5","volume":"36","author":"TY Xu","year":"2015","unstructured":"Xu TY, Lan XH, Guan YF, Zhang SL, Wang X, Miao CY. Chronic nicotine treatment enhances vascular smooth muscle relaxation in rats. Acta Pharmacol Sin. 2015;36:429\u201339.","journal-title":"Acta Pharmacol Sin"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","volume":"26","author":"KT Kimura","year":"2019","unstructured":"Kimura KT, Asada H, Inoue A, Kadji FMN, Im D, Mori C, et al. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. Nat Struct Mol Biol. 2019;26:121\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727\u201348.","journal-title":"J Mol Biol"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","volume":"351","author":"MT La Rovere","year":"1998","unstructured":"La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478\u201384.","journal-title":"Lancet."},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1161\/01.CIR.103.16.2072","volume":"103","author":"MT La Rovere","year":"2001","unstructured":"La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072\u20137.","journal-title":"Circulation."},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1097\/00004872-200209000-00033","volume":"20","author":"CY Miao","year":"2002","unstructured":"Miao CY, Su DF. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J Hypertens. 2002;20:1865\u201372.","journal-title":"J Hypertens"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ddr.10131","volume":"58","author":"CY Miao","year":"2003","unstructured":"Miao CY, Su DF. Arterial baroreflex function and left ventricular hypertrophy. Drug Dev Res. 2003;58:61\u20134.","journal-title":"Drug Dev Res"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00005344-200101000-00002","volume":"37","author":"CY Miao","year":"2001","unstructured":"Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF. Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol. 2001;37:6\u201315.","journal-title":"J Cardiovasc Pharmacol"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2005.03.037","volume":"183","author":"GJ Cai","year":"2005","unstructured":"Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis. 2005;183:41\u20137.","journal-title":"Atherosclerosis"},{"key":"636_CR23","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1161\/STROKEAHA.106.480061","volume":"38","author":"AJ Liu","year":"2007","unstructured":"Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex: a novel target for preventing stroke in rat hypertension. Stroke. 2007;38:1916\u201323.","journal-title":"Stroke"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1093\/eurheartj\/ehr299","volume":"34","author":"JG Yu","year":"2013","unstructured":"Yu JG, Song SW, Shu H, Fan SJ, Liu AJ, Liu C, et al. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-alpha7-nicotinic ACh receptor in rats. Eur Heart J. 2013;34:2412\u201320.","journal-title":"Eur Heart J"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1440-1681.2003.03788.x","volume":"30","author":"ZA Lu","year":"2003","unstructured":"Lu ZA, Xie HH, Xu LP, Yin AF, Miao CY, Su DF. Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture. Clin Exp Pharmacol Physiol. 2003;30:49\u201354.","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"636_CR26","doi-asserted-by":"publisher","unstructured":"Li Y, Feng Y, Liu L, Li X, Li XY, Sun X, et al. The baroreflex afferent pathway plays a critical role in H2S-mediated autonomic control of blood pressure regulation under physiological and hypertensive conditions. Acta Pharmacol Sin. 2020. https:\/\/doi.org\/10.1038\/s41401-020-00549-5.","DOI":"10.1038\/s41401-020-00549-5"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1440-1681.2007.04746.x","volume":"35","author":"W Zhang","year":"2008","unstructured":"Zhang W, Liu AJ, Yi-Ming W, Liu JG, Shen FM, Su DF. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2008;35:83\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"636_CR28","first-page":"S21","volume":"176","author":"SPH Alexander","year":"2019","unstructured":"Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019\/20: G protein-coupled receptors. Br J Pharmacol. 2019;176:S21\u2013S141.","journal-title":"Br J Pharmacol."},{"key":"636_CR29","first-page":"397","volume":"11","author":"CY Miao","year":"1990","unstructured":"Miao CY, Su DF. Negative chronotropic effect of ketanserin on the rat right atria and mechanism analysis. J Sec Milit Med Univ. 1990;11:397\u2013400.","journal-title":"J Sec Milit Med Univ."},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, et al. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors. Pharmacol Rev. 2015;67:601\u201355.","journal-title":"Pharmacol Rev."},{"key":"636_CR31","unstructured":"Taylor BN, Cassagnol M. Alpha Adrenergic Receptors. Treasure Island (FL): StatPearls Publishing; 2021."},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/pr.118.015552","volume":"73","author":"NM Barnes","year":"2021","unstructured":"Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, et al. International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacol Rev. 2021;73:310\u2013520.","journal-title":"Pharmacol Rev."},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"112290","DOI":"10.1016\/j.ejmech.2020.112290","volume":"195","author":"A Garrido","year":"2020","unstructured":"Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C. hERG toxicity assessment: useful guidelines for drug design. Eur J Med Chem. 2020;195:112290.","journal-title":"Eur J Med Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-021-00636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-021-00636-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-021-00636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:52Z","timestamp":1684616632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00636-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}